⌘K

Login Start Free

Home/Filings/4/0001235802-21-000091

4//SEC Filing

Kellen Scott 4

Accession 0001235802-21-000091

CIK 0001401040other

View on SEC.gov Company Profile

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 9:02 PM ET

Size

5.9 KB

Accession

0001235802-21-000091

Insider Transaction Report

Form 4

Period: 2021-07-28

DiaMedica Therapeutics Inc.DMAC

CFO & Secretary

Transactions

Award
Stock Option (right to buy)
2021-07-28+60,000→ 60,000 total
Exercise: $5.00Exp: 2031-07-27→ Common Shares (60,000 underlying)

Holdings

Voting Common Shares, no par value per share
12,290

Footnotes (1)

[F1]Vests in sixteen nearly equal quarterly installments over four years.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1

filerCIK 0001490476

Filing Metadata

Form type: 4
Filed: Jul 28, 8:00 PM ET
Accepted: Jul 29, 9:02 PM ET
Size: 5.9 KB

View on SEC.gov